Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Gujarat Kidney And Super Speciality PS Ratio?
Gujarat Kidney And Super SpecialityNSE:GKSL -0.99%18 PS Ratio is 10.14 as of Jul. 16, 2026, which is 6% below its 10-year median of 10.75. GuruFocus rates NSE:GKSL with a GF Score™ of 18/100. The stock has 5 warning signs investors should review. Among 661 Healthcare Providers & Services companies, Gujarat Kidney And Super Speciality ranks worse than 91.53% on this metric.
NSE:GKSL's PS Ratio is ranked worse than 91.53% of 661
companies
in the Healthcare Providers & Services industry
Industry Median: 1.51
vs NSE:GKSL: 10.13
Gujarat Kidney And Super Speciality (NSE:GKSL) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Gujarat Kidney And Super Speciality PS Ratio Related Terms
Gujarat Kidney And Super Speciality PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gujarat Kidney And Super Speciality PS Ratio Chart
Gujarat Kidney And Super Speciality Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
PS Ratio
0.00
0.00
0.00
7.69
Gujarat Kidney And Super Speciality Quarterly Data
For the Medical Care Facilities subindustry, Gujarat Kidney And Super Speciality's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gujarat Kidney And Super Speciality PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Gujarat Kidney And Super Speciality's PS Ratio distribution charts can be found below:
* The bar in red indicates where Gujarat Kidney And Super Speciality's PS Ratio falls into.
Gujarat Kidney And Super Speciality PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Gujarat Kidney And Super Speciality's Share Price of today is ₹131.43. Gujarat Kidney And Super Speciality's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹12.97.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Gujarat Kidney And Super Speciality (NSE:GKSL) has a PS Ratio of 10.14 as of Jul. 16, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Gujarat Kidney And Super Speciality and its competitors. This is near median its historical median of 10.75. Over the past decade, Gujarat Kidney And Super Speciality's PS Ratio has ranged from 8.00 to 12.24. According to the industry distribution chart, Gujarat Kidney And Super Speciality ranks #605 out of 661 companies in the Healthcare Providers & Services industry, placing it in the top 91.5%.
Is Gujarat Kidney And Super Speciality's PS Ratio too high?
Gujarat Kidney And Super Speciality's current PS Ratio of 10.14 is near median its 10-year median of 10.75. Over the past 10 years, this metric has ranged from a low of 8.00 to a high of 12.24. The Healthcare Providers & Services industry median PS Ratio is 1.51. Gujarat Kidney And Super Speciality's value of 10.14 is 571.5% above this industry median. Based on the distribution chart, Gujarat Kidney And Super Speciality ranks #605 out of 661 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Gujarat Kidney And Super Speciality has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Gujarat Kidney And Super Speciality's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Gujarat Kidney And Super Speciality ranks #605 out of 661 companies for PS Ratio. This places Gujarat Kidney And Super Speciality in the lower half of its industry. The industry median PS Ratio is 1.51. Gujarat Kidney And Super Speciality's value of 10.14 is 571.5% above this benchmark. Historically, Gujarat Kidney And Super Speciality's own PS Ratio has ranged from 8.00 to 12.24 over the past decade. While the company's 10-year median is 10.75 vs. the industry median of 1.51, Gujarat Kidney And Super Speciality has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.51, based on 661 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gujarat Kidney And Super Speciality's current PS Ratio of 10.14 is 571.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Gujarat Kidney And Super Speciality and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gujarat Kidney And Super Speciality's current PS Ratio is 10.14, which is near median its own 10-year median of 10.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Kidney And Super Speciality stock overvalued right now?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a current PS Ratio of 10.14. The current PS Ratio is 10.14, which is near median its 10-year median of 10.75 and 571.5% above the Healthcare Providers & Services industry median of 1.51. Gujarat Kidney And Super Speciality's overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Gujarat Kidney And Super Speciality (NSE:GKSL), the current PS Ratio is 10.14 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gujarat Kidney And Super Speciality Business Description
Gujarat Kidney And Super Speciality Ltd is engaged in the business of operating a chain of mid-sized multispeciality hospitals in central Gujarat and providing integrated healthcare services, with a focus on secondary and tertiary care. It offers a range of healthcare services, including General Medicine, General Surgery, Laparoscopic Surgery, Urology, Cardiology, Nephrology, and many more. The company operates in a single segment, namely Medical and Healthcare Services. It generates a substantial portion of revenue from its services to inpatients. Geographically, it operates only in India.
18GF Score
Get the complete analysis for NSE:GKSL
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GKSL has been successfully added to your 
